A detailed history of Libra Wealth LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Libra Wealth LLC holds 2,511 shares of ABBV stock, worth $411,402. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,511
Previous 2,821 10.99%
Holding current value
$411,402
Previous $437,000 4.58%
% of portfolio
0.2%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $49,544 - $56,451
-310 Reduced 10.99%
2,511 $457,000
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $27,520 - $30,994
-200 Reduced 6.62%
2,821 $437,000
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $15,767 - $18,909
-114 Reduced 3.64%
3,021 $488,000
Q3 2022

Oct 26, 2022

BUY
$134.21 - $153.93 $10,065 - $11,544
75 Added 2.45%
3,135 $421,000
Q4 2021

Apr 28, 2022

BUY
$107.43 - $135.93 $328,735 - $415,945
3,060 New
3,060 $414,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Libra Wealth LLC Portfolio

Follow Libra Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Libra Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Libra Wealth LLC with notifications on news.